Oligomeric proanthocyanidins
Useful mainly for people with chronic venous insufficiency or leg-vein symptoms.
Quick decision guide
May help most
people with chronic venous insufficiency or leg-vein symptoms
Common dosing range
100–300 mg/day standardized extract
When to expect effects
Weeks
Watch out for
may add to blood-thinning and blood-pressure-lowering effects
What is it
Oligomeric proanthocyanidins (OPCs) are a class of flavonoid antioxidants made of linked catechin/epicatechin units, found concentrated in grape seed, pine bark (Pycnogenol), and other plants. They are marketed for vascular health, antioxidant support, and skin. The best human evidence is for chronic venous insufficiency and modest blood-pressure effects, much of it from specific branded extracts.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
chronic venous insufficiency Limited Evidence | Modest | adults with chronic venous insufficiency, leg heaviness, or edema | Weeks |
blood pressure Limited Evidence | Small (~a few mmHg) | adults with elevated or high-normal blood pressure | Weeks |
chronic venous insufficiency
- Effect
- Modest
- Best fit
- adults with chronic venous insufficiency, leg heaviness, or edema
- Time
- Weeks
blood pressure
- Effect
- Small (~a few mmHg)
- Best fit
- adults with elevated or high-normal blood pressure
- Time
- Weeks
Evidence for 2 uses
AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.
chronic venous insufficiency
Supplement benefitMultiple randomized trials of grape seed and pine bark OPC extracts report reduced leg edema, heaviness, and related symptoms of chronic venous insufficiency versus placebo. Effects are modest and trials vary in extract and quality, but the direction of benefit is fairly consistent for this use.
Bottom line: Standardized OPC extracts give modest, fairly consistent relief of chronic venous insufficiency symptoms.
blood pressure
Biomarker supportMeta-analyses of grape seed extract trials show a small reduction in systolic (and sometimes diastolic) blood pressure, on the order of a few mmHg, more apparent in younger or metabolically at-risk subjects. This is a biomarker change; trials are short and do not show reductions in cardiovascular events.
Bottom line: May lower blood pressure by a few mmHg, but this is a biomarker effect, not proven outcome benefit.
Evidence is mixed
Average reductions are small and not seen consistently across all subgroups or trials.
How to take it
What to track
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Who should avoid it
- People on anticoagulants without medical advice
- People scheduled for surgery (stop beforehand)
Pregnancy & breastfeeding
Insufficient safety data for concentrated extracts in pregnancy or breastfeeding; avoid unless advised.
Interactions
OPCs may have mild antiplatelet activity, increasing bleeding risk.
Possible additive blood-pressure lowering.
Choosing a product
What to look for on the label — and what to be skeptical of.
Look for…
Be skeptical of…
References by claim
Track Oligomeric proanthocyanidins with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.
Coming to App StoreDisclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.